Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

2-Bromo-5-hydroxyphenylporphyrins for photodynamic therapy: photosensitization efficiency, subcellular localization and in vivo studies.

Laranjo M, Serra AC, Abrantes M, Piñeiro M, Gonçalves AC, Casalta-Lopes J, Carvalho L, Sarmento-Ribeiro AB, Rocha-Gonsalves A, Botelho F.

Photodiagnosis Photodyn Ther. 2013 Feb;10(1):51-61. doi: 10.1016/j.pdpdt.2012.05.003. Epub 2012 Jun 19.

PMID:
23465373
2.

Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.

Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.

Cancer Res. 2001 Aug 1;61(15):5824-32.

3.

Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro.

Kolarova H, Bajgar R, Tomankova K, Nevrelova P, Mosinger J.

Toxicol In Vitro. 2007 Oct;21(7):1287-91. Epub 2007 May 5.

PMID:
17561369
4.

Epigallocatechin gallate with photodynamic therapy enhances anti-tumor effects in vivo and in vitro.

Mun ST, Bae DH, Ahn WS.

Photodiagnosis Photodyn Ther. 2014 Jun;11(2):141-7. doi: 10.1016/j.pdpdt.2014.03.003. Epub 2014 Mar 13.

PMID:
24632332
5.

In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.

Zhao H, Yin R, Chen D, Ren J, Wang Y, Zhanga J, Deng H, Wang Y, Qiu H, Huang N, Zou Q, Zhao J, Gu Y.

Photodiagnosis Photodyn Ther. 2014 Jun;11(2):204-12. doi: 10.1016/j.pdpdt.2014.01.003. Epub 2014 Feb 14.

PMID:
24534694
6.

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

Cramers P, Ruevekamp M, Oppelaar H, Dalesio O, Baas P, Stewart FA.

Br J Cancer. 2003 Jan 27;88(2):283-90.

7.

Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.

Dąbrowski JM, Krzykawska M, Arnaut LG, Pereira MM, Monteiro CJ, Simões S, Urbańska K, Stochel G.

ChemMedChem. 2011 Sep 5;6(9):1715-26. doi: 10.1002/cmdc.201100186. Epub 2011 Jul 5.

PMID:
21732537
8.

Meso-tetraphenylporphyrin dimer derivative as a potential photosensitizer in photodynamic therapy.

Faustino MA, Neves MG, Vicente MG, Cavaleiro JA, Neumann M, Brauer HD, Jori G.

Photochem Photobiol. 1997 Oct;66(4):405-12.

PMID:
9337611
9.

Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development.

Kim YW, Bae SM, Liu HB, Kim IW, Chun HJ, Ahn WS.

Oncol Rep. 2012 Aug;28(2):576-84. doi: 10.3892/or.2012.1820. Epub 2012 May 17.

PMID:
22614712
10.

Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.

Date M, Fukuchi K, Namiki Y, Okumura A, Morita S, Takahashi H, Ohura K.

Liver Int. 2004 Apr;24(2):142-8.

PMID:
15078479
11.

Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.

Yan YJ, Zheng MZ, Chen ZL, Yu XH, Yang XX, Ding ZL, Xu L.

Bioorg Med Chem. 2010 Sep 1;18(17):6282-91. doi: 10.1016/j.bmc.2010.07.027. Epub 2010 Jul 16.

PMID:
20691601
12.

Photosensitization with methylene-linked porphyrin dimers.

Kessel D, Chang CK, Henderson BW.

J Photochem Photobiol B. 1993 May;18(2-3):177-80.

PMID:
8350184
13.

In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy.

Chen JJ, Hong G, Gao LJ, Liu TJ, Cao WJ.

J Cancer Res Clin Oncol. 2015 Sep;141(9):1553-61. doi: 10.1007/s00432-015-1918-1. Epub 2015 Jan 22.

PMID:
25609073
14.

Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative.

Alvarez MG, Morán F, Yslas EI, Vittar NB, Bertuzzi M, Durantini EN, Rivarola V.

Biomed Pharmacother. 2003 May-Jun;57(3-4):163-8.

PMID:
12818478
15.

Production of reactive oxygen species after photodynamic therapy by porphyrin sensitizers.

Kolarova H, Nevrelova P, Tomankova K, Kolar P, Bajgar R, Mosinger J.

Gen Physiol Biophys. 2008 Jun;27(2):101-5.

PMID:
18645224
16.

Photosensitizing effectiveness of a novel chlorin-based photosensitizer for photodynamic therapy in vitro and in vivo.

Zhang LJ, Bian J, Bao LL, Chen HF, Yan YJ, Wang L, Chen ZL.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1527-36. doi: 10.1007/s00432-014-1717-0. Epub 2014 May 27.

PMID:
24863752
17.

Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.

Colombo LL, Vanzulli SI, Villanueva A, Cañete M, Juarranz A, Stockert JC.

Int J Oncol. 2005 Oct;27(4):1053-9.

PMID:
16142323
18.

New potent sensitizers for photodynamic therapy: 21-oxaporphyrin, 21-thiaporphyrin and 21,23-dithiaporphyrin induce extensive tumor necrosis.

Ziólkowski P, Symonowicz K, Chmielewski P, Latos-Grazyński L, Streckyte G, Rotomskis R, Rabczyński J.

J Cancer Res Clin Oncol. 1999 Oct;125(10):563-8.

PMID:
10473869
19.

Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma.

Karagianis G, Hill JS, Stylli SS, Kaye AH, Varadaxis NJ, Reiss JA, Phillips DR.

Br J Cancer. 1996 Feb;73(4):514-21.

20.

Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.

Gomer CJ, Ryter SW, Ferrario A, Rucker N, Wong S, Fisher AM.

Cancer Res. 1996 May 15;56(10):2355-60.

Supplemental Content

Support Center